9438318

Source:http://linkedlifedata.com/resource/pubmed/id/9438318

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034196, umls-concept:C0087111, umls-concept:C0205250, umls-concept:C0231175, umls-concept:C1704419
pubmed:issue	12
pubmed:dateCreated	1998-3-19
pubmed:abstractText	In this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously failed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0060105
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antitrichomonal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin, http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Oxytetracycline, http://linkedlifedata.com/resource/pubmed/chemical/bismuth tripotassium dicitrate
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0036-5521
pubmed:author	pubmed-author:BergeTT, pubmed-author:FáraMM, pubmed-author:LerangFF, pubmed-author:MotzPP, pubmed-author:SandveiP KPK, pubmed-author:TønnesenTT, pubmed-author:TolåsPP, pubmed-author:ToroSS
pubmed:issnType	Print
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1209-14
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9438318-Adult, pubmed-meshheading:9438318-Aged, pubmed-meshheading:9438318-Amoxicillin, pubmed-meshheading:9438318-Anti-Bacterial Agents, pubmed-meshheading:9438318-Anti-Ulcer Agents, pubmed-meshheading:9438318-Antitrichomonal Agents, pubmed-meshheading:9438318-Clarithromycin, pubmed-meshheading:9438318-Drug Evaluation, pubmed-meshheading:9438318-Drug Therapy, Combination, pubmed-meshheading:9438318-Female, pubmed-meshheading:9438318-Helicobacter Infections, pubmed-meshheading:9438318-Helicobacter pylori, pubmed-meshheading:9438318-Humans, pubmed-meshheading:9438318-Male, pubmed-meshheading:9438318-Metronidazole, pubmed-meshheading:9438318-Microbial Sensitivity Tests, pubmed-meshheading:9438318-Middle Aged, pubmed-meshheading:9438318-Omeprazole, pubmed-meshheading:9438318-Organometallic Compounds, pubmed-meshheading:9438318-Oxytetracycline, pubmed-meshheading:9438318-Prospective Studies
pubmed:year	1997
pubmed:articleTitle	Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.
pubmed:affiliation	Dept. of Internal Medicine, Ostfold Central Hospital, Fredrikstad, Norway.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I